RT Journal Article
T1 Segmentectomy in Lung Cancer as a New Standard of Treatment: Can Less Be More?
A1 Isea de la Viña, Jesus
A1 Ramirez-Rodriguez, Gema
A1 Alcazar-Navarrete, Bernardino
K1 Treatment Outcome
K1 Neoplasm Staging
K1 Carcinoma, Non-Small-Cell Lung
AB Non-small cell lung cancer (NSCLC) remains the leading cause of cancer death worldwide,1 especially in patients with chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD). In recent decades, however, efforts to prevent, diagnose, and treat NSCLC have led to a decline in age-adjusted mortality rates (especially in men)2 and the detection of smaller tumors at the time of diagnosis.
PB Elsevier Doyma
YR 2022
FD 2022-06-20
LK http://hdl.handle.net/10668/22016
UL http://hdl.handle.net/10668/22016
LA en
LA es
NO Isea de la Viña J, Ramírez-Rodríguez G, Alcázar-Navarrete B. Segmentectomy in Lung Cancer as a New Standard of Treatment: Can Less Be More? Arch Bronconeumol. 2022 Oct;58(10):687-688.
DS RISalud
RD Apr 18, 2025